IP Library Patent Application 12434460
Patent Application
App. No. 12/434,460

CANNULA ENCLOSING RECESSED WAVEGUIDE OUTPUT TIP

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/434,460
Abstract

A cannula includes a proximal end, a distal end, and a cannula axis extending between the proximal end and the distal end. A lumen is disposed along at least a portion of the cannula between the proximal end and the distal end, and an energy output is configured to ablate a target surface, the energy output having a longitudinal axis and a tissue-disrupting distal end that is disposed within the lumen near the distal end. The tissue-disrupting distal end is configured to direct ablating energy in a direction toward the distal end of the cannula. The cannula axis and the longitudinal axis are concentric, and a region between the tissue-disrupting distal end and the distal end of the cannula is fixed and further can be transparent to a wavelength of energy emitted from the energy output.

Claims (26)

1 . A cannula comprising:

a proximal end, a distal end, and a cannula axis extending between the proximal end and the distal end;

a lumen disposed along at least a portion of the cannula between the proximal end and the distal end; and

an energy output configured to ablate a target surface, the energy output having a longitudinal axis and a tissue-disrupting distal end that is disposed within the lumen near the distal end, the tissue-disrupting distal end being configured to direct ablating energy in a direction toward the distal end of the cannula;

wherein the cannula axis and the longitudinal axis are about concentric and a region between the tissue-disrupting distal end and the distal end of the cannula is fixed and further is transparent to a wavelength of energy emitted from the energy output.

2 . The cannula as set forth in claim 1 , wherein the target surface is skin.

3 . The cannula as set forth in claim 1 , wherein the energy output is a fiber optic.

4 . The cannula as set forth in claim 1 , wherein the energy output is configured to emit electromagnetic energy, which comprises soft-tissue ablating electromagnetic energy.

5 . The cannula as set forth in claim 1 , wherein the energy output is configured to emit electromagnetic energy, which comprises low-level light therapy (LLLT) electromagnetic energy.

6 . The cannula as set forth in claim 1 , wherein the energy output is configured to emit electromagnetic energy, which comprises tissue-biostimulation electromagnetic energy.

7 . The cannula as set forth in claim 1 , wherein the energy output is configured to emit electromagnetic energy, which comprises visible electromagnetic energy.

8 . The cannula as set forth in claim 1 , wherein the energy output is configured to emit electromagnetic energy, which comprises coherent light.

9 . The cannula as set forth in claim 1 , and further comprising a fluid output configured to emit fluid in a vicinity of the distal end of the cannula.

10 . The cannula as set forth in claim 9 , wherein the fluid output is configured to direct liquid in a direction toward the tissue-disrupting distal end.

11 . The cannula as set forth in claim 9 , wherein the fluid is water.

12 . The apparatus as set forth in claim 11 , wherein the energy output is configured to emit electromagnetic energy, which comprises one of a wavelength within a range from about 2.69 to about 2.80 microns and a wavelength of about 2.94 microns.

13 . The apparatus as set forth in claim 11 , wherein the energy output is configured to emit electromagnetic energy, which is generated by one or more of an Er:YAG, an Er:YSGG, an Er, Cr:YSGG and a CTE:YAG laser.

14 . The apparatus as set forth in claim 11 , wherein the apparatus is a nasal-cavity operating apparatus and the target surface is nasal-cavity tissue.

15 . The apparatus as set forth in claim 11 , wherein the target surface comprises one or more of bone, cartilage and soft tissue.

16 . The apparatus as set forth in claim 1 , and further comprising a fluid output configured to emit fluid in a vicinity of the distal end of the cannula, wherein:

the fluid output comprises an atomizer configured to place atomized fluid particles into a volume above the target surface; and

the energy output is configured to impart relatively large amounts of energy into the atomized fluid particles in the volume above the target surface to thereby expand the atomized fluid particles and impart the disruptive forces onto the target surface.

17 . The apparatus as set forth in claim 16 , wherein the fluid particles comprise water.

18 . A cannula comprising a proximal end, a distal end, a cannula axis extending between the proximal end and the distal end, and a lumen existing along at least a portion of the cannula between the proximal end and the distal end, the cannula comprising an energy waveguide that has a waveguide axis that is disposed along the cannula axis and that is configured to treat a target surface, the energy output having a tissue-treating distal end positioned within the lumen near but not at the distal end, the tissue-treating distal end being configured to direct treatment energy in a direction toward the distal end of the cannula, and a volume between the tissue-treating distal end and the distal end of the cannula being unchangeable and unobstructed to a wavelength of energy emitted from the energy output.

19 . The apparatus as set forth in claim 18 , wherein the target surface is skin.

20 . The cannula as set forth in claim 18 , wherein the source of tissue displacement is a fiber optic.

Assignments (6)
CHANGE OF NAME Recorded Nov 20, 2012
From: BIOLASE TECHNOLOGY, INC.
To: BIOLASE, INC.
Reel/Frame 029328/0096 →
RELEASE OF SECURITY INTEREST Recorded May 9, 2012
From: HENRY SCHEIN, INC.
To: BIOLASE TECHNOLOGY, INC.; BL ACQUISTION CORP.; BL ACQUISITION II INC.
Reel/Frame 028184/0218 →
SECURITY AGREEMENT PAYOFF Recorded May 16, 2011
From: MIDCAP FINANCIAL, LLC, AGENT AND AS LENDER
To: BIOLASE TECHNOLOGY, INC.
Reel/Frame 026285/0666 →
SECURITY AGREEMENT Recorded Sep 30, 2010
From: BIOLASE TECHNOLOGY, INC.; BL ACQUISITION CORP.; BL ACQUISITION II INC.
To: HENRY SCHEIN, INC.
Reel/Frame 025066/0488 →
SECURITY AGREEMENT Recorded Aug 28, 2010
From: BIOLASE TECHNOLOGY, INC.
To: MIDCAP FINANCIAL, LLC, AS AGENT AND AS A LENDER
Reel/Frame 024900/0550 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 1, 2009
From: MCKEE, RONALD D.
To: BIOLASE TECHNOLOGY, INC.
Reel/Frame 022628/0470 →